Press Release

United States Veterinary Oncology Diagnostics Market to Grow with a CAGR of 8.48% through 2030

Growing adoption of advanced diagnostic tools and rising prevalence of cancer in companion animals are encouraging early detection and treatment, is expected to drive the United States Veterinary Oncology Diagnostics Market growth in the forecast period, 2026-2030

 

According to TechSci Research report, “United States Veterinary Oncology Diagnostics Market – By Region, Competition, Forecast & Opportunities, 2030F”, the United States Veterinary Oncology Diagnostics Market was valued at USD 985.24 Million in 2024 and is expected to reach USD 1607.87 Million by 2030 with a CAGR of 8.48%. The United States Veterinary Oncology Diagnostics Market is expanding rapidly due to advancements in technology and growing interest in pet health. Pet owners are increasingly aware of the risks associated with untreated cancers and are seeking early detection solutions to ensure their pets receive timely care. This awareness, coupled with a rising pet population and improved access to veterinary care, has increased the demand for innovative oncology diagnostics. The adoption of cutting-edge tools such as genetic testing, molecular imaging, and liquid biopsy has improved diagnostic accuracy and enabled personalized treatment approaches. These advancements allow for better identification of various cancer types in animals, from soft tissue tumors to more complex conditions, thus fueling market growth.

A significant trend in the market is the shift toward non-invasive diagnostic methods. Pet owners and veterinary professionals are moving away from traditional, invasive biopsy techniques in favor of less invasive alternatives such as blood tests and imaging technologies. These non-invasive methods reduce stress on pets and lead to quicker diagnosis and treatment. Another notable trend is the rise in collaborative care, where veterinary oncologists, general practitioners, and pet owners work together to formulate comprehensive treatment plans. Such collaborative approaches improve patient outcomes, creating greater demand for oncology diagnostics and treatment services.

There are several growth opportunities in the United States Veterinary Oncology Diagnostics Market, particularly in enhancing accessibility and affordability. Expanding pet insurance coverage to include more comprehensive oncology care would help reduce financial barriers and allow more pet owners to access advanced diagnostic and treatment services. The development of cost-effective diagnostic tools, such as affordable genetic tests and point-of-care devices, also presents a significant opportunity to make cancer diagnostics more accessible. Furthermore, increasing partnerships between veterinary clinics and diagnostic laboratories can improve service availability in underserved areas, ensuring that more pets can benefit from early cancer detection. As the market continues to grow, these opportunities can drive innovation and ensure better outcomes for both pets and their owners.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Veterinary Oncology Diagnostics Market

 

The United States Veterinary Oncology Diagnostics Market is segmented into animal type, test type, cancer type, end user, regional distribution, and company.

Based on the Cancer Type, Skin Cancers emerged as the fastest growing segment in the United States Veterinary Oncology Diagnostics Market during the forecast period. This is due to the increasing incidence of skin tumors in companion animals, particularly dogs and cats. The rise in skin cancer cases can be attributed to several factors, including greater exposure to environmental factors like UV radiation, which can lead to the development of tumors such as mast cell tumors, melanomas, and squamous cell carcinomas. As more pet owners become aware of the potential risks and signs of skin cancer, the demand for diagnostic testing has surged, fueling market growth. Veterinary practices are increasingly adopting advanced diagnostic tools, such as molecular diagnostics, histopathology, and imaging technologies, to accurately diagnose skin cancers at an early stage. Early detection is crucial for effective treatment and improving the prognosis of affected pets, driving the need for more specialized oncology diagnostics in the market.

Based on the Region, West emerged as the fastest growing region in the United States Veterinary Oncology Diagnostics Market during the forecast period. This is due to a combination of factors. The region is home to some of the country's leading veterinary hospitals and specialty oncology centers, offering advanced diagnostic and treatment options for pets. California, in particular, is known for its high concentration of pet owners who are increasingly proactive about their pets' health, including cancer prevention and early detection. The West also benefits from a robust healthcare infrastructure, which includes access to cutting-edge diagnostic technologies, such as molecular diagnostics, advanced imaging, and biomarker testing, facilitating early and accurate detection of cancer in animals. Additionally, veterinary professionals in the region are often at the forefront of adopting new technologies and treatment modalities, further driving market growth.

 

Major companies operating in United States Veterinary Oncology Diagnostics Market are:

  • Zoetis Inc.
  • Neogen Corporation
  • Antech Diagnostics, Inc.
  • IDEXX Laboratories, Inc.
  • Embark Veterinary, Inc.
  • Boehringer Ingelheim Animal Health USA Inc.
  • Arizona Veterinary Oncology
  • Varian Medical Systems, Inc.
  • Merck & Co., Inc.
  • Oncotect, Inc.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

The United States Veterinary Oncology Diagnostics Market is expanding due to the increasing investments in veterinary cancer research and the development of innovative diagnostic technologies. Research organizations and veterinary clinics are focusing on creating more efficient and affordable diagnostic tests for cancer in pets, thus increasing the accessibility of advanced diagnostic options for pet owners. Collaboration between veterinary healthcare providers and technology companies has led to the integration of artificial intelligence and machine learning in diagnostic tools, further improving the accuracy and efficiency of cancer detection. This shift toward advanced, data-driven diagnostics is enhancing the capabilities of veterinary professionals and contributing to the market’s growth”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

United States Veterinary Oncology Diagnostics Market By Animal Type (Canine, Feline, Others), By Test Type (Blood Tests, Biopsy, Genome Testing, Endoscopy, Urinalysis, Imaging), By Cancer Type (Lymphoma, Sarcomas, Mammary Gland Tumors, Skin Cancers, Others), By End User (Reference Laboratories, Veterinary Hospitals and Clinics, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of United States Veterinary Oncology Diagnostics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Veterinary Oncology Diagnostics Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com

Relevant Reports

United States Veterinary Oncology Diagnostics Market By Animal Type (Canine, Feline, Others), By Test Type (Blood Tests, Biopsy, Genome Testing, Endoscopy, Urinalysis, Imaging), By Cancer Type (Lymphoma, Sarcomas, Mammary Gland Tumors, Skin Cancers, Others), By End User (Reference Laboratories, Veterinary Hospitals and Clinics, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Healthcare | Apr, 2025

Rising pet ownership and increasing awareness of cancer risks in pets are leading to higher demand for early diagnostic solutions are the factors driving the United States Veterinary Oncology Diagnostics Market in the forecast period 2026-2030.

Relevant News